4//SEC Filing
Leupin Nicolas 4
Accession 0001562180-25-002163
CIK 0001645113other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:42 PM ET
Size
7.5 KB
Accession
0001562180-25-002163
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leupin Nicolas
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2025-03-04$18.19/sh+81,499$1,482,467→ 81,499 totalExercise: $18.19From: 2026-03-04Exp: 2035-03-03→ Ordinary Shares (81,499 underlying) - Award
Ordinary Shares
2025-03-04$18.19/sh+54,975$999,995→ 105,108 total
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0002007766
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:42 PM ET
- Size
- 7.5 KB